Presentation is loading. Please wait.

Presentation is loading. Please wait.

Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison  Stacy J. Chin, MD, Brian P. Vickery, MD, Michael D. Kulis,

Published byEdvard Carstensen Modified over 5 years ago

Similar presentations

Presentation on theme: "Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison  Stacy J. Chin, MD, Brian P. Vickery, MD, Michael D. Kulis,"— Presentation transcript:

1 Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison 
Stacy J. Chin, MD, Brian P. Vickery, MD, Michael D. Kulis, PhD, Edwin H. Kim, MD, Pooja Varshney, MD, Pamela Steele, CPNP, Janet Kamilaris, RN, Anne M. Hiegel, RN, Suzanna K. Carlisle, RN, P. Brian Smith, MD, MPH, MHS, Amy M. Scurlock, MD, Stacie M. Jones, MD, A. Wesley Burks, MD  Journal of Allergy and Clinical Immunology  Volume 132, Issue 2, Pages e2 (August 2013) DOI: /j.jaci Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 A and B, Change in serum peanut-IgE and peanut-IgG4 (SLIT/OIT). C, IgE/IgG4 ratio to peanut (SLIT/OIT). D, Cumulative amount tolerated during DBPCFC (SLIT/OIT). E, Serum peanut-IgE (pass/fail). F, Fold change in serum peanut-IgG4 from baseline to 12 months (pass/fail). Scatter plots show individual data with a line designating the median. Journal of Allergy and Clinical Immunology  , e2DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison  Stacy J. Chin, MD, Brian P. Vickery, MD, Michael D. Kulis,"

Similar presentations

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Molly A. Martin, MD, MAPP, Valerie G. Press, MD, MPH, Sharmilee M

Molly A. Martin, MD, MAPP, Valerie G. Press, MD, MPH, Sharmilee M
Corinne A. Keet, MD, MS, Pamela A

Corinne A. Keet, MD, MS, Pamela A
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy  Satya D. Narisety,

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy  Satya D. Narisety,
Risk of an asthma exacerbation after bariatric surgery in adults

Risk of an asthma exacerbation after bariatric surgery in adults
Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo- controlled multicenter trial  David M. Fleischer, MD, A. Wesley Burks,

Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo- controlled multicenter trial  David M. Fleischer, MD, A. Wesley Burks,
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
Alison M. Hofmann, MD, Amy M. Scurlock, MD, Stacie M

Alison M. Hofmann, MD, Amy M. Scurlock, MD, Stacie M
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy  Michael Kulis, PhD, Katie.

Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy  Michael Kulis, PhD, Katie.
Stacie M. Jones, MD, Scott H. Sicherer, MD, A

Stacie M. Jones, MD, Scott H. Sicherer, MD, A
Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A

Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical.

Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical.
Is the prevalence of peanut allergy increasing

Is the prevalence of peanut allergy increasing
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response  Pooja Varshney, MD, Stacie.

A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response  Pooja Varshney, MD, Stacie.
Allergy testing in predicting outcome of open food challenge to peanut

Allergy testing in predicting outcome of open food challenge to peanut
A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy  Justin M. Skripak, MD, Scott D. Nash, MD, Hannah.

A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy  Justin M. Skripak, MD, Scott D. Nash, MD, Hannah.

Similar presentations

Ads by Google